---
title: 'Senior Director, Market Access at Kardigan'
canonical: 'https://feeny.ai/job/senior-director-market-access-kardigan-princeton-new-jersey-jgykxc4nvvkh'
type: 'job'
last_seen: '2026-09-12'
---

# Senior Director, Market Access at Kardigan

- **Company:** Kardigan
- **Location:** Princeton New Jersey, United States
- **Compensation:** $255k–$340k
- **Posted:** 2026-07-01
- **Last confirmed live:** 2026-09-12
- **Apply:** https://job-boards.greenhouse.io/kardigan/jobs/5288100008

## Job description

## About Us

Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.

It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.

Led by Tassos Gianakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.

We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.

At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.

These values are the foundation of our work, empowering us to make a real difference, every day.

Position Title: Senior Director, Market Access

Department: Commercial

Reports To: VP Marketing. As the organization grows, this role is expect to transition to reporting to Chief Commercial Officer or Head of Market Access.

Location: Princeton, NJ – On-site 4 days per week (Mon to Thurs)

Job Overview

Kardigan is seeking a Senior Director of Market Access to help build the commercial foundation for our late-stage cardiovascular portfolio. This is a rare opportunity to join a pre-launch biotech with strong science, an experienced leadership team, and a clear path toward bringing transformative therapies to patients with serious heart disease. Reporting to the VP Marketing, this individual will be a key architect of Kardigan’s payer strategy, coverage policy, and access infrastructure - shaping how patients and providers can access our medicines from day one. The ideal candidate brings deep expertise across managed care, payer strategy, health economics, and patient services, and thrives in a fast-paced, high-accountability environment where building from the ground up is the norm.

Essential Duties and Responsibilities

- Lead the development and execution of market access strategies for multiple late-stage cardiovascular assets from pre-launch through commercialization, including coverage and reimbursement planning, payer value proposition, and pricing and contracting frameworks across commercial, Medicare, and Medicaid segments.
- Build and maintain relationships with national and regional payers, PBMs, and IDNs; lead payer advisory boards and negotiate formulary positioning for launch products.
- Partner with Medical Affairs and HEOR to define evidence generation priorities and to develop and communicate the clinical and economic value story that supports favorable coverage decisions and formulary placement.
- Design and oversee patient services programs including hub services, prior authorization support, patient assistance programs (PAP), and co-pay support to minimize access barriers and reduce time to therapy.
- Develop and execute a channel strategy spanning specialty pharmacy, specialty distributors, and hospital/institutional settings appropriate for a cardiovascular launch.
- Develop and lead the government affairs and policy strategy, including monitoring and responding to coverage policies, CMS proposals, and legislative dynamics that could affect product access.
- Collaborate cross-functionally with Commercial, Medical, Legal, Finance, and Regulatory to align on launch readiness milestones, pricing strategy, and access timelines.
- Build, manage, and mentor a high-performing market access team as the organization grows, including external vendors and agency partners as needed.
- Establish metrics, dashboards, and reporting frameworks to monitor payer coverage, patient access, and field reimbursement performance.
- Represent market access perspectives in launch planning, LCM activities, and pipeline asset development to ensure early integration of access considerations.

## Qualifications and Preferred Skills

- Bachelor’s degree required; advanced degree (MBA, MPH, PharmD, or equivalent) strongly preferred.
- 10+ years of pharmaceutical/biotech industry experience with at least 6 years in market access, managed care, payer strategy, or a closely related function.
- Prior experience with at least one US product launch is required; cardiovascular, cardiometabolic or specialty launch experience is strongly preferred. Rare/orphan disease experience preferred but not required.
- Deep knowledge of the US payer landscape including commercial health plans, PBMs, Medicare Part D, and Medicaid, including formulary management, prior authorization, and step therapy protocols.
- Demonstrated success in establishing and managing payer relationships and leading payer negotiations or contracting processes.
- Experience developing and implementing patient services programs, including hub/SP management, PAP, co-pay card, and field reimbursement support.
- Familiarity with HEOR principles and the ability to translate health economic data into payer-relevant messaging and dossiers.
- Strong strategic thinking, analytical skills, and executive presence, with the ability to influence cross-functional partners and present to senior leadership.
- Comfortable operating in a small, pre-commercial company environment; demonstrated ability to build programs and teams from early-stage through launch.
- Ability to travel up to 30% as needed to support payer meetings, industry conferences, and internal team collaboration.

Exact Compensation may vary based on skills, experience and location.

Pay range $255,000—$340,000 USD

## About Kardigan

## Company Overview
- **One-liner**: Kardigan is a publicly traded biopharmaceutical company developing targeted cardiovascular therapies with the aim of transforming treatment from symptom management toward functional cures.
- **Entity Type**: Public (ticker not available from provided sources; IPO closed as per company announcement)
- **Headquarters**: South San Francisco, California, United States (with additional offices in Princeton, New Jersey and Chicago, Illinois)
- **Founded**: Year not specified in available sources
- **Founders**: Tassos Gianakakos (Co-Founder, CEO & Chair), Dr. Jay Edelberg (Co-Founder & Chief Medical Officer), Dr. Bob McDowell (Co-Founder & Scientific Adviser), Brianne Puglisi (Co-Founder)

## Core Business
- **Primary industry**: Biopharmaceuticals – cardiovascular drug discovery and development
- **Target customers**: B2B / B2G – healthcare providers, hospitals, payers, and patients; the company develops prescription medicines for serious cardiovascular conditions
- **Mission or purpose statement**: “To make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.” ([kardigan.bio](https://www.kardigan.bio/))

## Products & Services
- **Tonlamarsen**: A Phase 2/3 candidate for acute severe hypertension (ASH) and uncontrolled hypertension. Positive Phase 2 data presented as a late-breaker at ACC.26 and simultaneously published in JACC. ([kardigan.bio](https://www.kardigan.bio/))
- **Danicamtiv**: A Phase 3 candidate for genetic dilated cardiomyopathy (DCM), targeting the underlying inherited cardiac muscle disease. ([kardigan.bio](https://www.kardigan.bio/))
- **Calcific Aortic Valve Stenosis (CAVS) Program**: A late-stage clinical program addressing calcium deposition that stiffens the aortic valve. ([kardigan.bio](https://www.kardigan.bio/))
- **Prolaio Subsidiary**: An AI and real‑world data platform integrated into Kardigan to generate insights, inform clinical trial design, and reduce time/cost of drug development. ([kardigan.bio](https://www.kardigan.bio/about-us/))
- **Cardiac Intelligence Platform**: A discovery and translational research engine that uses real‑world patient data, AI, and deep cardiovascular expertise to identify disease drivers and design targeted therapies. ([kardigan.bio](https://www.kardigan.bio/))

## Market Standing
- **Valuation/Market Cap**: Not disclosed in provided sources
- **Key Metric**: Public company (IPO closed); annual revenue not disclosed
- **Notable Investors/Partners**: Not explicitly listed in provided sources; company built on the team’s track record from MyoKardia (acquired by Bristol Myers Squibb for $13.1B in 2020)
- **Growth Signals**:
  - Positive Phase 2 pivotal data for Tonlamarsen in hypertension, presented at ACC.26 and published in JACC
  - Three late‑stage clinical programs (CAVS, ASH, DCM) running in parallel
  - Active job postings across 210+ roles in clinical operations, data science, manufacturing, and corporate strategy, indicating scaling ([job-boards.greenhouse.io/kardigan](http://job-boards.greenhouse.io/kardigan))
  - Integration of Prolaio’s AI platform to accelerate R&D

## Competitive Advantages
- **Leadership expertise**: CEO Tassos Gianakakos previously scaled MyoKardia from startup to a $13.1B acquisition; the team includes veterans from MyoKardia, Sanofi, BMS, and Merck.
- **Parallel pipeline strategy**: Multiple late‑stage programs targeting distinct cardiovascular diseases (valve, hypertension, cardiomyopathy) de‑risks development and creates data synergies.
- **Cardiac Intelligence platform**: Proprietary combination of real‑world data, AI, and deep biological insight to move beyond symptom management toward modifying underlying disease.
- **Focus on functional cures**: Each program aims to alter the course of disease rather than merely treat symptoms, creating potential for breakthrough efficacy.

## Strategic Focus
- **Advance late‑stage clinical trials**: Continue Phase 2/3 studies for Tonlamarsen, Danicamtiv, and CAVS while preparing for potential regulatory submissions.
- **Expand platform capabilities**: Leverage Prolaio’s AI and real‑world evidence to design smarter, faster trials and discover new drug targets.
- **Build commercial infrastructure**: Growing corporate strategy, medical affairs, and manufacturing teams in South San Francisco, Princeton, and Chicago signals preparation for launch.

## Why Work Here
- **Culture**: “Everything we do starts with patients – and it’s powered by people.” Emphasis on collaboration, purpose‑driven work, and achieving the impossible together. Mission‑oriented environment focused on curing cardiovascular disease. ([kardigan.bio](https://www.kardigan.bio/job-openings/))
- **Work model**: Roles are listed for South San Francisco, Princeton, NJ, and Chicago, IL; likely on‑site/hybrid given the lab and clinical development nature. Not purely remote.
- **Benefits**:
  - Competitive salaries and annual bonus program
  - Comprehensive medical, dental, and vision coverage
  - 401(k) plan, life and disability insurance
  - Flexible spending and health savings accounts
  - Commuter benefits, cellphone allowance
  - Paid holidays and time off
  - Employee assistance program ([kardigan.bio](https://www.kardigan.bio/job-openings/))
- **Engineering & data science culture**: Active recruitment for data analytics, AI, and clinical data science roles; Executive Director of Data, AI & Collaboration Services is an open position, reflecting a strong tech‑driven R&D approach.

## Sources
1. [kardigan.bio](https://www.kardigan.bio/) – Company homepage and pipeline descriptions
2. [kardigan.bio/about-us](https://www.kardigan.bio/about-us/) – About Us, mission, and Prolaio integration
3. [kardigan.bio/job-openings](https://www.kardigan.bio/job-openings/) – Careers page with benefits and open roles
4. [kardigan.bio/leadership](https://www.kardigan.bio/leadership/) – Leadership team and co‑founder backgrounds
5. [job-boards.greenhouse.io/kardigan](http://job-boards.greenhouse.io/kardigan) – Detailed job listings (32+ postings)

## Other roles at Kardigan

- [Senior Director, Product Strategy](https://feeny.ai/job/senior-director-product-strategy-kardigan-princeton-new-jersey-zrx68wcapady) — Princeton New Jersey, United States
- [Sr. Director, Clinical Trial Optimization](https://feeny.ai/job/sr-director-clinical-trial-optimization-kardigan-princeton-new-jersey-05t1jx6jawfw) — Princeton New Jersey, United States
- [Director, Demand/Supply Planning](https://feeny.ai/job/director-demand-supply-planning-kardigan-south-san-francisco-jcz16k67hq5r) — South San Francisco, CA
- [Scientist, Drug Metabolism and Pharmacokinetics (DMPK)](https://feeny.ai/job/scientist-drug-metabolism-and-pharmacokinetics-dmpk-kardigan-south-san-x3c0x3gmm3r7) — South San Francisco California, United States
- [Sr. Executive Assistant - Contract to Hire](https://feeny.ai/job/sr-executive-assistant-contract-to-hire-kardigan-south-san-francisco-s62w5nabntfw) — South San Francisco, CA
- [Director, Clinical Trial Liaison West](https://feeny.ai/job/director-clinical-trial-liaison-west-kardigan-united-states-t8xmqj8mg16m) — United States
- [Senior Director, CMC Regulatory](https://feeny.ai/job/senior-director-cmc-regulatory-kardigan-princeton-new-jersey-74vt09gwp1cj) — Princeton New Jersey, United States
- [Senior Director, CMC Regulatory](https://feeny.ai/job/senior-director-cmc-regulatory-kardigan-south-san-francisco-california-xjzf831d0r9n) — South San Francisco California, United States
- [Head of Medical Affairs](https://feeny.ai/job/head-of-medical-affairs-kardigan-princeton-rq45s28mr31y) — Princeton, NJ
- [Director, Product Quality Lead](https://feeny.ai/job/director-product-quality-lead-kardigan-south-san-francisco-california-united-ft71es75vxe9) — South San Francisco California United States Princeton New Jersey, United States